Lansoprazole Injection

Healthy Inc is a specialized global supplier and exporter of high-stability proton pump inhibitors (PPIs). We provide high-purity Lansoprazole Injection (30 mg), sourced from WHO–GMP certified sterile lyophilized facilities. This “Gastric Acid” specialist is a top export to gastroenterology wards, surgical recovery units, and government health ministries in Africa, LATAM, and Southeast Asia, serving as a rapid and potent alternative for acid suppression in patients unable to tolerate oral therapy.

Product Overview

This formulation contains Lansoprazole Sodium, a substituted benzimidazole that acts as a specific proton pump inhibitor.

The “Rapid-Release” Specialist:

• Mechanism (The “Final Blockade”): Lansoprazole is a prodrug that accumulates in the acidic secretory canaliculi of the gastric parietal cell. There, it is converted into its active sulfenamide form, which covalently binds to the H+/K+ ATPase enzyme (the proton pump). This permanently disables the pump, blocking the final step of acid secretion.
• Bioavailability Advantage: Intravenous Lansoprazole provides 100% bioavailability immediately, ensuring rapid pH control (pH > 4 or > 6) which is critical for clot stability in peptic ulcer bleeding.
• Stress Ulcer Prophylaxis: It is widely used in ICU settings to prevent stress-related mucosal damage (SRMD) in ventilated or critically ill patients.

Product Composition & Strength

We supply this product as a Sterile Lyophilized Powder for Injection in glass vials.

*Pack Sizes: Tray of 1 Vial, 10 Vials, or Box of 1/10 Vials.

Technical & Logistics Specifications

Critical data for Pharmaceutical Importers and Distributors.

Manufacturing Authority

Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.

• Lyophilization Cycle: Lansoprazole is heat-sensitive. Our manufacturing utilizes a specialized low-temperature lyophilization cycle (“freeze-drying”) to remove moisture without degrading the active molecule, resulting in a porous cake that dissolves instantly.
• Alkaline Stability: PPIs are unstable in acidic environments. Our formulation includes alkaline buffers (Meglumine/NaOH) to ensure the solution remains stable after reconstitution, preventing precipitation in the IV bag.

Therapeutic Indications (Human Use)

Indicated for short-term treatment (up to 7 days) when oral administration is not possible:

• Erosive Esophagitis: Treatment and healing of severe acid reflux damage.
• Peptic Ulcer Disease: Gastric and Duodenal ulcers.
• Hypersecretory Conditions: Pathological hypersecretion including Zollinger-Ellison Syndrome.
• GI Bleeding: Adjunct therapy to prevent rebleeding after endoscopic hemostasis.

Dosage & Administration

Recommended Dosage (Strictly as per Physician):

• Route: Intravenous (IV) Infusion ONLY.
• Standard Dose: 30 mg once daily.
• Infusion Time: Administer over 30 minutes.
• Reconstitution Protocol (CRITICAL):
  • Step 1: Inject 5 ml of Sterile Water for Injection into the vial. Shake gently until dissolved.
  • Step 2: Dilute the reconstituted solution in 50 ml of 0.9% Sodium Chloride (Saline) or 5% Dextrose/Lactated Ringer’s.
  • Filter: Unlike some other PPIs, standard Lansoprazole formulations usually require the use of an in-line filter (1.2 micron) during infusion to catch any micro-precipitates (check specific brand insert).

Safety Warnings (CRITICAL):

• Infusion Reaction: Rapid infusion can cause anaphylactoid reactions. Do not inject as an IV Bolus (“Push”). Must be infused over 30 mins.
• Liver Impairment: Dose reduction (15 mg) may be needed in severe hepatic dysfunction.
• Hypomagnesemia: Monitor magnesium levels in patients on prolonged therapy or diuretics.
• Interaction: May decrease absorption of drugs dependent on gastric pH (e.g., Ketoconazole, Iron salts).

Global Export & Contract Manufacturing Services

Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving the needs of international Pharma Traders, Wholesalers, and Bulk Drug Distributors. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for Sterile Injectables, allowing brands to launch high-quality generic medicines under their own label. Whether you are looking for a reliable Hospital Tender Supplier for government procurement in Africa or a B2B Pharma Marketplace partner for Latin America, our logistics network ensures timely delivery. We actively support Pharmaceutical Drop Shipping models and bulk indenting, ensuring that every Generic Medicine Wholesaler receives WHO-GMP certified products at competitive rates.